Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 242709, 8 pages
http://dx.doi.org/10.1155/2015/242709
Review Article

Impact of Volatile Anesthetics on Oxidative Stress and Inflammation

Division of Food Bioscience, College of Biomedical & Health Sciences, Konkuk University, Chungwon-daero 268, Chungju-si, Chungcheongbuk-do 380-701, Republic of Korea

Received 29 January 2015; Accepted 10 March 2015

Academic Editor: Bensu Karahalil

Copyright © 2015 Yoon-Mi Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. I. Eger II, “New inhaled anesthetics,” Anesthesiology, vol. 80, no. 4, pp. 906–922, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Esper, M. Wehner, C. D. Meinecke, and H. Rueffert, “Blood/Gas partition coefficients for isoflurane, sevoflurane, and desflurane in a clinically relevant patient population,” Anesthesia and Analgesia, vol. 120, no. 1, pp. 45–50, 2015. View at Publisher · View at Google Scholar
  3. E. D. Kharasch, M. D. Karol, C. Lanni, and R. Sawchuk, “Clinical sevoflurane metabolism and disposition: I. Sevoflurane and metabolite pharmacokinetics,” Anesthesiology, vol. 82, no. 6, pp. 1369–1378, 1995. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Bito, “Metabolism and toxicity of anesthetics,” Masui. The Japanese Journal of Anesthesiology, vol. 48, supplement, pp. S172–S179, 1999. View at Google Scholar · View at Scopus
  5. S. Reuter, S. C. Gupta, M. M. Chaturvedi, and B. B. Aggarwal, “Oxidative stress, inflammation, and cancer: how are they linked?” Free Radical Biology and Medicine, vol. 49, no. 11, pp. 1603–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. K. Vincent and A. G. Taylor, “Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans,” International Journal of Obesity, vol. 30, no. 3, pp. 400–418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. Lim, “Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells,” BMB Reports, vol. 47, no. 7, pp. 405–410, 2014. View at Publisher · View at Google Scholar
  8. T. Finkel, “Signal transduction by reactive oxygen species,” The Journal of Cell Biology, vol. 194, no. 1, pp. 7–15, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. B. C. Song, N.-S. Joo, G. Aldini, and K.-J. Yeum, “Biological functions of histidine-dipeptides and metabolic syndrome,” Nutrition Research and Practice, vol. 8, no. 1, pp. 3–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. L. H. Sanders and J. T. Greenamyren, “Oxidative damage to macromolecules in human Parkinson disease and the rotenone model,” Free Radical Biology and Medicine, vol. 62, pp. 111–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Sugamura and J. F. Keaney Jr., “Reactive oxygen species in cardiovascular disease,” Free Radical Biology & Medicine, vol. 51, no. 5, pp. 978–992, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. P. Hussain, L. J. Hofseth, and C. C. Harris, “Radical causes of cancer,” Nature Reviews Cancer, vol. 3, no. 4, pp. 276–285, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. L. J. Kuo and L.-X. Yang, “γ-H2AX—a novel biomaker for DNA double-strand breaks,” In Vivo, vol. 22, no. 3, pp. 305–310, 2008. View at Google Scholar · View at Scopus
  14. L. L. Wu, C.-C. Chiou, P.-Y. Chang, and J. T. Wu, “Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics,” Clinica Chimica Acta, vol. 339, no. 1-2, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Harma, A. Kocyigit, and O. Erel, “Increased DNA damage in patients with complete hydatidiform mole,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 583, no. 1, pp. 49–54, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Pizzimenti, C. Toaldo, P. Pettazzoni, M. U. Dianzani, and G. Barrera, “The ‘two-faced’ effects of reactive oxygen species and the lipid peroxidation product 4-Hydroxynonenal in the hallmarks of cancer,” Cancers, vol. 2, no. 2, pp. 338–363, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Ho, K. K. Galougahi, C.-C. Liu, R. Bhindi, and G. A. Figtree, “Biological markers of oxidative stress: applications to cardiovascular research and practice,” Redox Biology, vol. 1, no. 1, pp. 483–491, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Wang, L. Wang, N. L. Li et al., “Subanesthetic isoflurane reduces zymosan-induced inflammation in murine Kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 851692, 13 pages, 2014. View at Publisher · View at Google Scholar
  19. Y. Wu, S. Antony, J. L. Meitzler, and J. H. Doroshow, “Molecular mechanisms underlying chronic inflammation-associated cancers,” Cancer Letters, vol. 345, no. 2, pp. 164–173, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. F. J. Pashkow, “Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?” International Journal of Inflammation, vol. 2011, Article ID 514623, 9 pages, 2011. View at Publisher · View at Google Scholar
  21. S. P. Hussain and C. C. Harris, “Inflammation and cancer: an ancient link with novel potentials,” International Journal of Cancer, vol. 121, no. 11, pp. 2373–2380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. A. Jones, “Directing transition from innate to acquired immunity: defining a role for IL-6,” Journal of Immunology, vol. 175, no. 6, pp. 3463–3468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. T. D. Gilmore, “Introduction to NF-κB: players, pathways, perspectives,” Oncogene, vol. 25, no. 51, pp. 6680–6684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. J. S. C. Arthur and S. C. Ley, “Mitogen-activated protein kinases in innate immunity,” Nature Reviews Immunology, vol. 13, no. 9, pp. 679–692, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Danesh, J. G. Wheeler, G. M. Hirschfield et al., “C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease,” The New England Journal of Medicine, vol. 350, no. 14, pp. 1387–1397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Mitsuhata, R. Shimizu, and M. M. Yokoyama, “Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells,” International Journal of Immunopharmacology, vol. 17, no. 6, pp. 529–534, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Rodríguez-González, A. Baluja, S. V. del Río et al., “Effects of sevoflurane postconditioning on cell death, inflammation and TLR expression in human endothelial cells exposed to LPS,” Journal of Translational Medicine, vol. 11, no. 1, article 87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Yue, B. Roth Z'Graggen, S. Blumenthal et al., “Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro,” The European Respiratory Journal, vol. 31, no. 1, pp. 118–125, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. K. A. Boost, T. Leipold, P. Scheiermann et al., “Sevoflurane and isoflurane decrease TNF-alpha-induced gene expression in human monocytic THP-1 cells: potential role of intracellular IkappaBalpha regulation,” International Journal of Molecular Medicine, vol. 23, no. 5, pp. 665–671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Ye, Q. Lian, M. F. Eckenhoff, R. G. Eckenhoff, and J. Z. Pan, “Differential general anesthetic effects on microglial cytokine expression,” PLoS ONE, vol. 8, no. 1, Article ID e52887, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Schallner, F. Ulbrich, H. Engelstaedter et al., “Isoflurane but not sevoflurane or desflurane aggravates injury to neurons in vitro and in vivo via p75NTR-NF-κB activation,” Anesthesia and Analgesia, vol. 119, no. 6, pp. 1429–1441, 2014. View at Publisher · View at Google Scholar
  32. M. Jamnicki-Abegg, D. Weihrauch, P. S. Pagel et al., “Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression,” Anesthesiology, vol. 103, no. 5, pp. 1006–1014, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Bedirli, E. U. Bagriacik, H. Emmez, G. Yilmaz, Y. Unal, and Z. Ozkose, “Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia,” Journal of Neurosurgical Anesthesiology, vol. 24, no. 4, pp. 336–344, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. X. Shen, N. Bhatt, J. Xu et al., “Effect of isoflurane on myocardial energetic and oxidative stress in cardiac muscle from Zucker diabetic fatty rat,” The Journal of Pharmacology and Experimental Therapeutics, vol. 349, no. 1, pp. 21–28, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Mu, K. Xie, L. Hou et al., “Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice,” Shock, vol. 34, no. 2, pp. 183–189, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. J.-T. Li, H. Wang, W. Li et al., “Anesthetic isoflurane posttreatment attenuates experimental lung injury by inhibiting inflammation and apoptosis,” Mediators of Inflammation, vol. 2013, Article ID 108928, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Hofstetter, K. A. Boost, M. Flondor et al., “Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats,” Acta Anaesthesiologica Scandinavica, vol. 51, no. 7, pp. 893–899, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. R. V. Plachinta, J. K. Hayes, L. A. Cerilli, and G. F. Rich, “Isoflurane pretreatment inhibits lipopolysaccharide-induced inflammation in rats,” Anesthesiology, vol. 98, no. 1, pp. 89–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. I. K. Herrmann, M. Castellon, D. E. Schwartz et al., “Volatile anesthetics improve survival after cecal ligation and puncture,” Anesthesiology, vol. 119, no. 4, pp. 901–906, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Bedirli, C. Y. Demirtas, T. Akkaya et al., “Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation,” The Journal of Surgical Research, vol. 178, no. 1, pp. E17–E23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Z. F. dal Molin, C. R. P. Kruel, R. S. de Fraga, C. Alboim, J. R. de Oliveira, and M. R. Alvares-da-Silva, “Differential protective effects of anaesthesia with sevoflurane or isoflurane: an animal experimental model simulating liver transplantation,” European Journal of Anaesthesiology, vol. 31, no. 12, pp. 695–700, 2014. View at Publisher · View at Google Scholar
  42. H. Orhan, A. Sahin, G. Sahin, U. Aypar, and N. P. E. Vermeulen, “Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: potential biomarkers for a subclinical nephrotoxicity,” Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals, vol. 18, no. 1, pp. 73–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Karabiyik, S. Şardaş, U. Polat, N. A. Kocabaş, and A. E. Karakaya, “Comparison of genotoxicity of sevoflurane and isoflurane in human lymphocytes studied in vivo using the comet assay,” Mutation Research, vol. 492, no. 1-2, pp. 99–107, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Alleva, M. Tomasetti, M. D. Solenghi et al., “Lymphocyte DNA damage precedes DNA repair or cell death after orthopaedic surgery under general anaesthesia,” Mutagenesis, vol. 18, no. 5, pp. 423–428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. T. A. Crozier, J. E. Muller, D. Quittkat, M. Sydow, W. Wuttke, and D. Kettler, “Effect of anaesthesia on the cytokine responses to abdominal surgery,” British Journal of Anaesthesia, vol. 72, no. 3, pp. 280–285, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. J. J. Ke, J. Zhan, X. B. Feng, Y. Wu, Y. Rao, and Y.-L. Wang, “A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and anti-inflammatory cytokines in patients undergoing open cholecystectomy,” Anaesthesia and Intensive Care, vol. 36, no. 1, pp. 74–78, 2008. View at Google Scholar · View at Scopus
  47. Y. Jin, X. Zhao, H. Li, Z. Wang, and D. Wang, “Effects of sevofurane and propofol on the inflammatory response and pulmonary function of perioperative patients with one-lung ventilation,” Experimental and Therapeutic Medicine, vol. 6, no. 3, pp. 781–785, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M. G. Braz, L. G. Braz, B. S. Barbosa et al., “DNA damage in patients who underwent minimally invasive surgery under inhalation or intravenous anesthesia,” Mutation Research, vol. 726, no. 2, pp. 251–254, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. G. Braz, M. A. Mazoti, J. Giacobino et al., “Genotoxicity, cytotoxicity and gene expression in patients undergoing elective surgery under isoflurane anaesthesia,” Mutagenesis, vol. 26, no. 3, pp. 415–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Türkan, A. Aydin, A. Sayal, and B. Karahalil, “The effect of sevoflurane and desflurane on markers of oxidative status in erythrocyte,” Toxicology and Industrial Health, vol. 27, no. 2, pp. 181–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. M. G. Braz, L. G. Braz, J. R. Braz et al., “Comparison of oxidative stress in ASA physical status I patients scheduled for minimally invasive surgery under balanced or intravenous anesthesia,” Minerva Anestesiologica, vol. 79, no. 9, pp. 1030–1038, 2013. View at Google Scholar · View at Scopus
  52. J. E. Orosz, L. G. Braz, A. L. Ferreira et al., “Balanced anesthesia with sevoflurane does not alter redox status in patients undergoing surgical procedures,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 773, pp. 29–33, 2014. View at Publisher · View at Google Scholar
  53. T. Schilling, A. Kozian, M. Senturk et al., “Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients,” Anesthesiology, vol. 115, no. 1, pp. 65–74, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. E. de Conno, M. P. Steurer, M. Wittlinger et al., “Anesthetic-induced improvement of the inflammatory response to one-lung ventilation,” Anesthesiology, vol. 110, no. 6, pp. 1316–1326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. J. E. B. Orosz, M. G. Braz, M. A. Golim et al., “Cytokine profile in patients undergoing minimally invasive surgery with balanced anesthesia,” Inflammation, vol. 35, no. 6, pp. 1807–1813, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. K. Szyfter, R. Szulc, A. Mikstacki, I. Stachecki, M. Rydzanicz, and P. Jałoszyński, “Genotoxicity of inhalation anaesthetics: DNA lesions generated by sevoflurane in vitro and in vivo,” Journal of Applied Genetics, vol. 45, no. 3, pp. 369–374, 2004. View at Google Scholar · View at Scopus
  57. E. R. D. C. Paes, M. G. Braz, J. T. da Lima et al., “DNA damage and antioxidant status in medical residents occupationally exposed to waste anesthetic gases,” Acta Cirurgica Brasileira, vol. 29, no. 4, pp. 280–286, 2014. View at Publisher · View at Google Scholar · View at Scopus